We’re delighted to announce that ACNR has joined Crossref, and will be allocating DOI’s to new articles. We have also started adding DOI’s to existing articles, but as we have been publishing for almost 20 years we have quite a lot of content to work through! If you have published an article with us in…
New real-world data for ONGENTYS®▼ (opicapone) released at the MDS
New data presented 12-16 September at the MDS 2020 Virtual Congress further support the efficacy and tolerability of ONGENTYS® (opicapone) observed in pivotal Phase III studies. Opicapone is a once-daily catechol-O-methyltransferase (COMT) inhibitor, approved for the treatment of end-of-dose motor fluctuations in adult PD patients taking levodopa. Data from OPTIPARK study demonstrated consistently low incidence of treatment-related adverse events in clinical practice from the…
Funding boost for AI-based epilepsy monitoring
University spinout company Neuronostics has received funding to develop its BioEP platform, an AI-based system for faster, more accurate diagnosis of epilepsy and to monitor response to treatment with anti-epileptic drugs (AEDs). BioEP works by creating mathematical models of the brain using short segments of electroencephalogram (EEG) recordings. Computer simulations rapidly reveal the ease with…
SPRAVATO®▼ (esketamine) nasal spray for treatment-resistant major depressive disorder recommended in Scotland – but not England
The Janssen Pharmaceutical Companies of Johnson & Johnson are delighted that the Scottish Medicines Consortium (SMC) accepted SPRAVATO®▼ (esketamine) nasal spray (7th September 2020) for use within NHS Scotland in combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI), for adults with treatment-resistant Major Depressive Disorder (TRD), who have not responded…
Teva launches pre-filled pen for anti-CGRP migraine therapy AJOVY®▼ (fremanezumab) in the UK
On 21st July 2020, Teva UK Limited announced that a pre-filled pen for AJOVY® (fremanezumab) injection is now available, which will give patients on AJOVY® added convenience and flexibility not previously available with the AJOVY® pre-filled syringe. Indicated for the prevention of migraine in adults who have at least 4 migraine days per month, AJOVY®…
UKABIF Film Award Winner
Sacha Paynter from Bristol has won the United Kingdom Acquired Brain Injury Forum (UKABIF) Film Award for her film ‘Talking Benefits’, sponsored by Cygnet Health Care. Sacha’s short film looks at the importance of neurorehabilitation for individuals who have had an Acquired Brain Injury (ABI). The film is based on Sacha’s personal family experiences of…
Online auction for Newly Injured Scheme
Neurokinex, a specialist paralysis rehabilitation charity with sites at Gatwick, Hemel and Bristol, is running an online auction for two weeks from noon on Friday July 17th until noon on Friday July 31st to raise funds to safeguard the future of its Newly Injured Scheme. The auction includes a wide choice of lots including sports…
Hereditary Spastic Paraplegia (HSP) Support Group
News from The Hereditary Spatic Paraplegia Support Group
Nearly a third of scientists could leave neuroscience research due to COVID-19
News from The British Neuroscience Association
